Steve R. Ommen

Cardiology and Cardiovascular Medicine · 2000–2020

A researcher in the Science corpus: 11 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Steve R. Ommen trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. B. Maron
  2. M. Maron
  3. Iacopo Olivotto
  4. P. Spirito

Who trusts Steve R. Ommen overall

  1. M. Redfield
  2. Steven Jacobsen
  3. B. Maron
  4. W. Paulus

Papers from Steve R. Ommen's perspective

Ordered by how strongly the researchers Steve R. Ommen trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (Circulation)
  2. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). (European Heart Journal)
  3. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
  4. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. (New England Journal of Medicine)
  5. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice (EMBO Journal)
  6. The RAF proteins take centre stage (Nature reviews. Molecular cell biology)
  7. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
  8. Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome
  9. Germline mutations in HRAS proto-oncogene cause Costello syndrome (Nature Genetics)
  10. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. (Journal of the American College of Cardiology)

Their papers